News

Word count: 2,270 TWST: We’ve spoken before, but just for readers who may not be familiar, let’s start with a refresher on the company, its mission, and some milestones. Mr. Do: BioVie has two ...
In addition, the event will highlight M6P's S1S3 co-expression platform technology, designed to enhance mannose 6-phosphate (M6P) content on lysosomal enzymes to increase lysosomal targeting to ...
In addition, the event will highlight M6P's S1S3 co-expression platform technology, designed to enhance mannose 6-phosphate (M6P) content on lysosomal enzymes to increase lysosomal targeting to ...
Sanofi has developed a simpler way to create site-specific antibody-to-mannose-6-phosphate (M6P) conjugates that eliminates the need for enzyme remodeling. This more straightforward method makes ...
See the latest McPhy Energy SA stock price (M6P:XMUN), related news, valuation, dividends and more to help you make your investing decisions.
Marisa Leuzzi, Toronto, ON, M6P, (647) 952-6585, Are you a caregiver looking for support for your child or teen experiencing behavioural challenges? I can understand how difficult it can be to ...
Reenie Perkovic, Registered Psychotherapist (Qualifying), Toronto, ON, M6P, (416) 966-5123, I’m Reenie (she/they) and I’m a queer therapist who values the importance of lived experiences and ...
In five poster presentations, including two Contemporary Forum presentations, M6P Therapeutics’ researchers report preclinical efficacy results for LSDs, including Gaucher disease and Pompe disease.
M6P Therapeutics announced a poster presentation at the 29th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) 2022.
GCase uptake and distribution in the CNS was also evaluated by immunohistochemical staining About M6P Therapeutics M6P Therapeutics is a privately held, venture-backed biotechnology company developing ...
- Preclinical data provide proof of concept for M002 to restore cellular uptake and lysosomal delivery and attenuate phenotype in mouse models of mucolipidosis type II - - M002 leverages the Company’s ...